Business Description
Telomir Pharmaceuticals Inc
NAICS : 541713
SIC : 2834
Description
Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.72 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.14 | |||||
| 9-Day RSI | 52.07 | |||||
| 14-Day RSI | 52.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.33 | |||||
| Quick Ratio | 0.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -587.68 | |||||
| ROA % | -313.45 | |||||
| ROIC % | -60.42 | |||||
| ROCE % | -510.97 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 60.58 | |||||
| Price-to-Tangible-Book | 60.58 | |||||
| EV-to-EBIT | -18.58 | |||||
| EV-to-EBITDA | -18.58 | |||||
| EV-to-FCF | -52.69 | |||||
| Earnings Yield (Greenblatt) % | -5.38 | |||||
| FCF Yield % | -1.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TELO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Telomir Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.425 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 52.18 | ||
| 14-Day ATR ($) | 1.112523 | ||
| 20-Day SMA ($) | 7.243255 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 4.76 - 20.72 | ||
| Shares Outstanding (Mil) | 29.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Telomir Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Telomir Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Telomir Pharmaceuticals Inc Frequently Asked Questions
What is Telomir Pharmaceuticals Inc(TELO)'s stock price today?
The current price of TELO is $7.27. The 52 week high of TELO is $20.72 and 52 week low is $4.76.
When is next earnings date of Telomir Pharmaceuticals Inc(TELO)?
The next earnings date of Telomir Pharmaceuticals Inc(TELO) is .
Does Telomir Pharmaceuticals Inc(TELO) pay dividends? If so, how much?
Telomir Pharmaceuticals Inc(TELO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers